Role of Cytoplasmic Phospholipase A2in Endothelium-Derived Hyperpolarizing Factor Dilations of Rat Middle Cerebral Arteries
Authors:
Open Access
- 1 October 2002
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 22 (10) , 1239-1247
Abstract
Very little is known regarding the mechanism of action for the endothelium-derived hyperpolarizing factor (EDHF) response in cerebral vessels. The authors tested two hypotheses: (1) activation of the cytoplasmic form of phospholipase A2(cPLA2) is involved with EDHF-mediated dilations in rat middle cerebral arteries; and (2) activation of the cPLA2involves an increase in endothelial Ca2+through activation of phospholipase C. Middle cerebral arteries were isolated from the rat, pressurized to 85 mm Hg, and luminally perfused. The EDHF response was elicited by luminal application of uridine triphosphate (UTP) after NO synthase and cyclooxygenase inhibition (10−5mol/L N-nitro-l-arginine methyl ester and 10−5mol/L indomethacin, respectively). AACOCF3and PACOCF3, inhibitors of cPLA2(Ca2+-sensitive) and Ca2+-insensitive PLA2(iPLA2), dose dependently attenuated the EDHF response. A selective inhibitor for iPLA2, haloenol lactone suicide substrate, had no effect on the EDHF response. The EDHF response elicited by UTP was accompanied by an increase in endothelial Ca2+(144 to 468 nmol/L), and the EDHF dilation was attenuated with U73122, a phospholipase C inhibitor. The authors conclude that the EDHF response elicited by luminal UTP in rat middle cerebral arteries involved activation of phospholipase C, an increase in endothelial Ca2+, and activation of cPLA2.Keywords
This publication has 46 references indexed in Scilit:
- Lysophospholipids--Receptor RevelationsScience, 2001
- Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vesselsBritish Journal of Pharmacology, 2000
- Apamin-sensitive, non-nitric oxide (NO) endothelium-dependent relaxations to bradykinin in the bovine isolated coronary artery: no role for cytochrome P450and K+British Journal of Pharmacology, 2000
- P 2u Receptor–Mediated Release of Endothelium-Derived Relaxing Factor/Nitric Oxide and Endothelium-Derived Hyperpolarizing Factor From Cerebrovascular Endothelium in RatsStroke, 1999
- REGULATION AND INHIBITION OF PHOSPHOLIPASE A2Annual Review of Pharmacology and Toxicology, 1999
- Sex differences in the relative contributions of nitric oxide and EDHF to agonist‐stimulated endothelium‐dependent relaxations in the rat isolated mesenteric arterial bedBritish Journal of Pharmacology, 1998
- Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric arteryBritish Journal of Pharmacology, 1997
- Stimulation of α2Adrenoceptors Dilates the Rat Middle Cerebral ArteryAnesthesiology, 1996
- Relationship of Arachidonic Acid Release to Porcine Coronary Artery RelaxationHypertension, 1995
- Specific incorporation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid into phosphatidylcholine in human endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986